Angiotensin-converting enzyme inhibitor therapy for ventricular dysfunction in infants, children and adolescents: a review (Q34103464)

31 July 2017

title

Angiotensin-converting enzyme inhibitor therapy for ventricular dysfunction in infants, children and adolescents: a review (English)

1 reference

31 July 2017

1 reference

ventricular dysfunction

1 reference

Grenier MA

1 reference

31 July 2017

Fioravanti J

1 reference

31 July 2017

Truesdell SC

1 reference

31 July 2017

Mendelsohn AM

1 reference

31 July 2017

Vermilion RP

1 reference

31 July 2017

Lipshultz SE

1 reference

31 July 2017

publication date

1 November 2000

1 reference

Progress in pediatric cardiology

31 July 2017

published in

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

page(s)

91-111

1 reference

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Natural history of incidentally discovered, asymptomatic idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Role of bradykinin in the antihypertrophic effects of enalapril in the newborn pig heart

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Chronic effects of enalapril and amlodipine on cardiac remodeling in cardiomyopathic hamster hearts

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

The kinetic profiles of enalapril and enalaprilat and their possible developmental changes in pediatric patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Plasma renin activity in infants with congenital heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Enalapril in children with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Enalapril for severe heart failure in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

1 reference

7 January 2021

Angiotensin-Converting Enzyme Inhibitors Promote Nitric Oxide Production in Coronary Microvessels from Failing Explanted Human Hearts

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Regression of cardiac hypertrophy normalizes glucose metabolism and left ventricular function during reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Treatment of neonatal hypertension with enalaprilat

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Within-patient comparison of effects of different dosages of enalapril on functional capacity and neurohormone levels in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Cardiovascular drugs in children. II. Angiotensin-converting enzyme inhibitors in pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Orally administered enalapril for infants with congestive heart failure: a dose-finding study

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Efficacy and dosage of enalapril in congenital and acquired heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Inhibition of angiotensin converting enzyme with enalapril maleate in infants with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Acute hemodynamic effects of converting enzyme inhibition in infants with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Captopril in infants for congestive heart failure secondary to a large ventricular left-to-right shunt

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Captopril in treatment of infant heart failure: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Captopril in heart failure secondary to a left to right shunt

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Beneficial effects of 1-year captopril therapy in children with chronic aortic regurgitation who have no symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

[Life-threatening swelling of the tongue in antihypertensive therapy with ACE inhibitors]

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Captopril: 4 years of post marketing surveillance of all patients in New Zealand

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Captopril-induced bone marrow suppression in two cardiac patients with trisomy 21

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Intravenous enalaprilat and oral enalapril in congestive heart failure secondary to ventricular septal defect in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Resistance to captopril in hypertension of coarctation of the aorta

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Effect of captopril on blood pressure and on the renin-angiotensin-aldosterone system in coarctation of the aorta

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

A case of aortitis syndrome with severe coarctation of the aorta

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Sequential echocardiographic study prior and during antihypertensive therapy in children with severe hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Recovery from neonatal myocardial dysfunction after treatment of acute hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Pharmacologic management of childhood hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Acute renal failure with ACE inhibition in aortic coarctation.

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Hypertension in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Pediatric hypertension: clinical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Chronic MK421 fails to modify evolution of hypertension in neonatally coarcted pups

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Role of the renin-angiotensin-aldosterone system in hypertensive children with coarctation of the aorta

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Role of Neurohumoral Systems for Pressure Induced Left Ventricular Hypertrophy in Experimental Supravalvular Aortic Stenosis in Rats

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Cardiorespiratory response during exercise in patients with cyanotic congenital heart disease with and without a Fontan operation and in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Angiotensin-converting enzyme inhibitors in adults with cyanotic congenital heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Ventricular performance before and after Fontan repair for univentricular atrioventricular connection: angiographic and radionuclide assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Enalapril Does Not Enhance Exercise Capacity in Patients After Fontan Procedure

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Acute hemodynamic effects of captopril in children with a congestive or restrictive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Captopril in children with dilated cardiomyopathy: acute and long-term effects in a prospective study of hemodynamic and hormonal effects.

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Captopril in children with cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Effects of cardiac versus circulatory angiotensin-converting enzyme inhibition on left ventricular diastolic function and coronary blood flow in hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Effects of enalapril on adriamycin-induced nephrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Ventricular remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Protective effect of captopril on ischemic myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Collagen synthesis by cultured cardiac fibroblasts obtained from cardiomyopathic hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Prolonging action of imidapril on the lifespan expectancy of cardiomyopathic hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

Can clonidine, enoximone, and enalaprilat help to protect the myocardium against ischaemia in cardiac surgery?

1 reference

https://api.crossref.org/works/10.1016%2FS1058-9813%2800%2900061-8

7 January 2021

10.1016/S1058-9813(00)00061-8

Identifiers

DOI

1 reference

31 July 2017

1 reference